Dechert Advises Yestar Group on $200M Restructuring
March 16, 2024
March 16, 2024
PHILADELPHIA, Pennsylvania, March 16 -- Dechert, a law firm, issued the following news on March 15, 2024:
Dechert has advised Yestar Healthcare Holdings Company Limited, a leading distributor and service provider of in vitro diagnostic products in the PRC, on its successful restructuring of its New York law governed US$200 million senior notes (the Notes).
The consensual restructuring, supported by an overwhelming majority of holders of the Notes and sanctioned by the C . . .
Dechert has advised Yestar Healthcare Holdings Company Limited, a leading distributor and service provider of in vitro diagnostic products in the PRC, on its successful restructuring of its New York law governed US$200 million senior notes (the Notes).
The consensual restructuring, supported by an overwhelming majority of holders of the Notes and sanctioned by the C . . .